{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T12:24:22Z","timestamp":1782217462973,"version":"3.54.5"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T00:00:00Z","timestamp":1673913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Visceral leishmaniasis is a major, life-threatening parasitic disease that still remains a serious public health problem in Ethiopia. Understanding the epidemiological, clinical, and hematological profiles of visceral leishmaniasis patients is important for implementing evidence-based control strategies. It is also important for early treatment and to decrease the mortality rate from the disease. Therefore, this study was aimed at assessing the epidemiological, clinical, and hematological profiles of visceral leishmaniasis among patients visiting Tefera Hailu Memorial Hospital, Northeast Ethiopia. A retrospective study was conducted at Tefera Hailu Memorial Hospital from September 2017 to August 2021. Data were collected from the medical records of suspected patients who were tested by the rK39 rapid diagnostic by strictly following standard operating procedures. The data was summarized using Microsoft Excel and analyzed using SPSS 26 version software. Descriptive statistics were used to describe the epidemiological, clinical, and hematological profiles of visceral leishmaniasis patients. A p-value\u2009&lt;\u20090.05 was considered statistically significant. The overall positivity rate for visceral leishmaniasis was 23.4% (132\/564). The result of this study indicated a fluctuating yet declining trend in VL over the past 4\u00a0years. From a total of 132 VL confirmed cases, the numbers of cases were highest among males (78.0%), those 15\u201329\u00a0years of age (37.1%), and urban residents (89.4%). Furthermore, Abergele (11.0%), Sehala (6.0%), and Ziquala (5.0%) districts had the highest number of VL cases. The major clinical presentations of patients were fever (96.2%), splenomegaly (94.7%), and general weakness (80.3%). With regard to hematological profiles, the most common findings were anemia (86.4%), thrombocytopenia (81.8%), leucopenia (78.8%), neutropenia (74.2%), and pancytopenia (71.2%). In the study area, the VL positivity rate was high. Our findings also concluded that VL causes significant alterations in clinical and hematological parameters. Therefore, the zone health office and other concerned stakeholders should strengthen evidence-based control programs for VL.<\/jats:p>","DOI":"10.1038\/s41598-023-28139-5","type":"journal-article","created":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T17:03:17Z","timestamp":1673974997000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Epidemiological, clinical and hematological profiles of visceral leishmaniasis among patients visiting Tefera Hailu Memorial Hospital, Northeast Ethiopia: a 4\u00a0year retrospective study"],"prefix":"10.1038","volume":"13","author":[{"given":"Habtu","family":"Debash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habtye","family":"Bisetegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marye","family":"Nigatie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Getu","family":"Abeje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Getacher","family":"Feleke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,17]]},"reference":[{"issue":"2","key":"28139_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1365-2915.2012.01034.x","volume":"27","author":"M Maroli","year":"2013","unstructured":"Maroli, M., Feliciangeli, M., Bichaud, L., Charrel, R. & Gradoni, L. Phlebotomine sandflies and the spreading of leishmaniases and other diseases of public health concern. Med. Vet. Entomol. 27(2), 123\u2013147 (2013).","journal-title":"Med. Vet. Entomol."},{"issue":"2","key":"28139_CR2","first-page":"57","volume":"2","author":"S Gulati","year":"2009","unstructured":"Gulati, S., Paljor, H., Pandit, S. & Jindal, R. Kala Azar without splenomegaly. Ann. Trop. Med. Public Health. 2(2), 57 (2009).","journal-title":"Ann. Trop. Med. Public Health."},{"issue":"1","key":"28139_CR3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.4103\/0377-4929.59193","volume":"53","author":"KK Dhingra","year":"2010","unstructured":"Dhingra, K. K. et al. Morphological findings in bone marrow biopsy and aspirate smears of visceral Kala Azar: A review. Indian J. Pathol. Microbiol. 53(1), 96 (2010).","journal-title":"Indian J. Pathol. Microbiol."},{"issue":"4","key":"28139_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1590\/S0037-86822010000400010","volume":"43","author":"CHN Costa","year":"2010","unstructured":"Costa, C. H. N. et al. Is severe visceral leishmaniasis a systemic inflammatory response syndrome? A case control study. Rev. Soc. Bras. Med. Trop. 43(4), 386\u2013392 (2010).","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"1","key":"28139_CR5","first-page":"1","volume":"2020","author":"CG Stark","year":"2020","unstructured":"Stark, C. G. Visceral leishmaniasis: Clinical manifestations and diagnosis. Drugs Infect. Dis. 2020(1), 1\u20135 (2020).","journal-title":"Drugs Infect. Dis."},{"issue":"1","key":"28139_CR6","doi-asserted-by":"publisher","first-page":"e2017056","DOI":"10.4084\/mjhid.2017.056","volume":"9","author":"J Al-Ghazaly","year":"2017","unstructured":"Al-Ghazaly, J., Al-Dubai, W., Abdullah, M. & Al-Gharasi, L. Hematological characteristics of Yemeni adults and children with visceral leishmaniasis. Mediterr. J. Hematol. Infect. Dis. 9(1), e2017056 (2017).","journal-title":"Mediterr. J. Hematol. Infect. Dis."},{"issue":"1","key":"28139_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.35500\/jghs.2020.2.e3","volume":"2","author":"RG Wamai","year":"2020","unstructured":"Wamai, R. G., Kahn, J., McGloin, J. & Ziaggi, G. Visceral leishmaniasis: A global overview. J. Glob. Health Sci. 2(1), 1\u201322 (2020).","journal-title":"J. Glob. Health Sci."},{"issue":"3","key":"28139_CR8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/0972-9062.191335","volume":"53","author":"T Hailu","year":"2016","unstructured":"Hailu, T., Yimer, M., Mulu, W. & Abera, B. Challenges in visceral leishmaniasis control and elimination in the developing countries: A review. J. Vector Borne Dis. 53(3), 193 (2016).","journal-title":"J. Vector Borne Dis."},{"issue":"11","key":"28139_CR9","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1503\/cmaj.050511","volume":"172","author":"A Anema","year":"2005","unstructured":"Anema, A. & Ritmeijer, K. Treating HIV\/AIDS and leishmaniasis coinfection in Ethiopia. Can. Med. Assoc. J. 172(11), 1434\u20131435 (2005).","journal-title":"Can. Med. Assoc. J."},{"issue":"2","key":"28139_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.4081\/gh.2013.88","volume":"7","author":"T Tsegaw","year":"2013","unstructured":"Tsegaw, T. et al. Identification of environmental parameters and risk mapping of visceral leishmaniasis in Ethiopia. Geospat. Health 7(2), 299\u2013308 (2013).","journal-title":"Geospat. Health"},{"issue":"3","key":"28139_CR11","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0035-9203(01)90223-8","volume":"95","author":"P Desjeux","year":"2001","unstructured":"Desjeux, P. The increase in risk factors for leishmaniasis worldwide. Trans. R. Soc. Trop. Med. Hyg. 95(3), 239\u2013243 (2001).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"28139_CR12","first-page":"1","volume":"305","author":"P Cec\u00edlio","year":"2022","unstructured":"Cec\u00edlio, P., Cordeiro-da-Silva, A. & Oliveir, F. Sand flies: Basic information on the vectors of leishmaniasis and their interactions with Leishmania parasites. Commun. Biol. 305(5), 1\u201312 (2022).","journal-title":"Commun. Biol."},{"issue":"1","key":"28139_CR13","doi-asserted-by":"publisher","DOI":"10.35500\/jghs.2020.2.e3","volume":"2","author":"RG Wamai","year":"2020","unstructured":"Wamai, R. G., Kahn, J., McGloin, J. & Ziaggi, G. Visceral leishmaniasis: A global overview. J. Glob. Health Sci. 2(1), e3 (2020).","journal-title":"J. Glob. Health Sci."},{"issue":"1","key":"28139_CR14","first-page":"135","volume":"12","author":"G Grifferty","year":"2021","unstructured":"Grifferty, G. et al. Vulnerabilities to and the socioeconomic and psychosocial impacts of the leishmaniases: A review. Res. Rep. Trop. Med. 12(1), 135 (2021).","journal-title":"Res. Rep. Trop. Med."},{"key":"28139_CR15","unstructured":"Organization WH. Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030 (2020)."},{"key":"28139_CR16","unstructured":"Population EOot, Commission HC. Summary and statistical report of the 2007 population and housing census: Federal Democratic Republic of Ethiopia, Population Census Commission (2008)."},{"issue":"8","key":"28139_CR17","doi-asserted-by":"publisher","first-page":"e0010624","DOI":"10.1371\/journal.pntd.0010624","volume":"16","author":"J Khabsa","year":"2022","unstructured":"Khabsa, J. et al. Stakeholders\u2019 views and perspectives on treatments of visceral leishmaniasis and their outcomes in HIV-coinfected patients in East Africa and South-East Asia: A mixed methods study. PLoS Negl. Trop. Dis. 16(8), e0010624 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"28139_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-06527-4","volume":"21","author":"G Dawit","year":"2021","unstructured":"Dawit, G. et al. Performance of rapid rk39 tests for the diagnosis of visceral leishmaniasis in Ethiopia: A systematic review and meta-analysis. BMC Infect. Dis. 21(1), 1 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"28139_CR19","first-page":"1","volume":"11","author":"T Hailu","year":"2016","unstructured":"Hailu, T. One Health approach prospect for integrated control and elimination of visceral leishmaniasis in Ethiopia: A narrative review article. Iran. J. Parasitol. 11(1), 1 (2016).","journal-title":"Iran. J. Parasitol."},{"issue":"1","key":"28139_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.bjid.2017.04.007","volume":"21","author":"V Kumar","year":"2017","unstructured":"Kumar, V., Tiwari, N., Gedda, M. R., Haque, R. & Singh, R. K. Leishmania donovani infection activates Toll-like receptor 2, 4 expressions and Transforming growth factor-beta mediated apoptosis in renal tissues. Braz. J. Infect. Dis. 21(1), 545\u2013549 (2017).","journal-title":"Braz. J. Infect. Dis."},{"issue":"5","key":"28139_CR21","first-page":"10.16966","volume":"1","author":"Y Shiferaw","year":"2016","unstructured":"Shiferaw, Y., Wondimeneh, Y., Wondifraw, H. & Ferede, G. Trend analysis of visceral leishmaniasis in Metema Hospital Northwest. Ethiopia. J. Epidemiol. Public Health Rev. 1(5), 10.16966 (2016).","journal-title":"J. Epidemiol. Public Health Rev."},{"issue":"1","key":"28139_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40794-020-00125-z","volume":"6","author":"A Gize","year":"2020","unstructured":"Gize, A., Workineh, A. & Hailu, T. A trend prevalence of visceral Leishmaniasis in West Armachiho District, Amhara Region, Northwest Ethiopia. Trop. Dis. Travel Med. Vaccines. 6(1), 1\u20135 (2020).","journal-title":"Trop. Dis. Travel Med. Vaccines."},{"key":"28139_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/545393","volume":"2014","author":"Y Wondimeneh","year":"2014","unstructured":"Wondimeneh, Y., Takele, Y., Atnafu, A., Ferede, G. & Muluye, D. Trend analysis of visceral leishmaniasis at Addis Zemen health center, Northwest Ethiopia. BioMed Res. Int. 2014, 1\u20135 (2014).","journal-title":"BioMed Res. Int."},{"issue":"9","key":"28139_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.trstmh.2008.03.021","volume":"102","author":"E Negera","year":"2008","unstructured":"Negera, E. et al. Outbreak of cutaneous leishmaniasis in Silti woreda, Ethiopia: Risk factor assessment and causative agent identification. Trans. R. Soc. Trop. Med. Hyg. 102(9), 883\u2013890 (2008).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"10","key":"28139_CR25","doi-asserted-by":"publisher","first-page":"e0183583","DOI":"10.1371\/journal.pone.0183583","volume":"12","author":"BV Purse","year":"2017","unstructured":"Purse, B. V. et al. How will climate change pathways and mitigation options alter incidence of vector-borne diseases? A framework for leishmaniasis in South and Meso-America. PLoS ONE 12(10), e0183583 (2017).","journal-title":"PLoS ONE"},{"issue":"1","key":"28139_CR26","first-page":"1","volume":"9","author":"B Tarekegn","year":"2021","unstructured":"Tarekegn, B. & Tamene, A. Clinical and laboratory profiles of visceral leishmaniasis among adult patients admitted to Felege Hiwot Hospital, Bahir Dar, Ethiopia. SAGE Open Med. 9(1), 1\u20136 (2021).","journal-title":"SAGE Open Med."},{"issue":"2","key":"28139_CR27","first-page":"1","volume":"3","author":"D Sumbria","year":"2017","unstructured":"Sumbria, D. & Singla, L. Worldwide weather transformation on vector and vector-borne parasitic infections. ARC J. Anim. Vet. Sci. 3(2), 1\u201310 (2017).","journal-title":"ARC J. Anim. Vet. Sci."},{"issue":"1","key":"28139_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-015-0987-y","volume":"8","author":"E Gadisa","year":"2015","unstructured":"Gadisa, E. et al. Eco-epidemiology of visceral leishmaniasis in Ethiopia. Parasites Vectors. 8(1), 1\u201310 (2015).","journal-title":"Parasites Vectors."},{"issue":"9","key":"28139_CR29","doi-asserted-by":"publisher","first-page":"e3131","DOI":"10.1371\/journal.pntd.0003131","volume":"8","author":"S Leta","year":"2014","unstructured":"Leta, S., Dao, T. H. T., Mesele, F. & Alemayehu, G. Visceral leishmaniasis in Ethiopia: An evolving disease. PLoS Negl. Trop. Dis. 8(9), e3131 (2014).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"8","key":"28139_CR30","doi-asserted-by":"publisher","first-page":"e00723","DOI":"10.1016\/j.heliyon.2018.e00723","volume":"4","author":"A Assefa","year":"2018","unstructured":"Assefa, A. Leishmaniasis in Ethiopia: A systematic review and meta-analysis of prevalence in animals and humans. Heliyon. 4(8), e00723 (2018).","journal-title":"Heliyon."},{"key":"28139_CR31","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2016.08.021","volume":"51","author":"K Gamal","year":"2016","unstructured":"Gamal, K. et al. Trend in cumulative cases and mortality rate among visceral leishmaniasis patients in Eastern Sudan: A 14-year registry, 2002\u20132015. Int. J. Infect. Dis. 51, 81\u201384 (2016).","journal-title":"Int. J. Infect. Dis."},{"key":"28139_CR32","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1186\/s12889-020-08532-9","volume":"20","author":"Evalyne Wambui Kanyina","year":"2020","unstructured":"Evalyne Wambui Kanyina. Characterization of visceral leishmaniasis outbreak, Marsabit County, Kenya, 2014. BMC Public Health 20, 446 (2020).","journal-title":"BMC Public Health"},{"issue":"1","key":"28139_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.4269\/ajtmh.2005.73.74","volume":"73","author":"A Ranjan","year":"2005","unstructured":"Ranjan, A. et al. Risk factors for Indian kala-azar. Am. J. Trop. Med. Hyg. 73(1), 74\u201378 (2005).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"28139_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4269\/ajtmh.2009.81.34","volume":"81","author":"S Bashaye","year":"2009","unstructured":"Bashaye, S. et al. Risk factors for visceral leishmaniasis in a new epidemic site in Amhara Region, Ethiopia. Am. J. Trop. Med. Hyg. 81(1), 34 (2009).","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"28139_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13071-018-2707-x","volume":"11","author":"R Mandal","year":"2018","unstructured":"Mandal, R., Kesari, S., Kumar, V. & Das, P. Trends in spatio-temporal dynamics of visceral leishmaniasis cases in a highly-endemic focus of Bihar, India: An investigation based on GIS tools. Parasit. Vectors 11(1), 1\u20139 (2018).","journal-title":"Parasit. Vectors"},{"issue":"2","key":"28139_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3126\/ijim.v2i2.8320","volume":"2","author":"Y Agrawal","year":"2013","unstructured":"Agrawal, Y. et al. Hematological profile in visceral leishmaniasis. Int. J. Infect. Microbiol. 2(2), 39\u201344 (2013).","journal-title":"Int. J. Infect. Microbiol."},{"issue":"12","key":"28139_CR37","doi-asserted-by":"publisher","first-page":"e0006888","DOI":"10.1371\/journal.pntd.0006888","volume":"12","author":"CA Bulstra","year":"2018","unstructured":"Bulstra, C. A. et al. Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India. PLoS Negl. Trop. Dis. 12(12), e0006888 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"issue":"1","key":"28139_CR38","first-page":"1","volume":"2020","author":"G Gebremichail","year":"2020","unstructured":"Gebremichail, G. et al. Hematological alteration among visceral leishmaniasis patients attending in Western Tigrai, Ethiopia. BMC Public Health 2020(1), 1\u201317 (2020).","journal-title":"BMC Public Health"},{"key":"28139_CR39","unstructured":"Naveed, S. S., Raza, N., Bux, H., Firdous, M. & Rafi, B. A clinico-haematological study of visceral leishmaniasis from northern Pakistan. Med. Channel. 17(3) (2011)."},{"issue":"3","key":"28139_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.4103\/0974-777X.68528","volume":"2","author":"N Ezra","year":"2010","unstructured":"Ezra, N., Ochoa, M. T. & Craft, N. Human immunodeficiency virus and leishmaniasis. J. Glob. Infect. Dis. 2(3), 248 (2010).","journal-title":"J. Glob. Infect. Dis."},{"issue":"1","key":"28139_CR41","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2015.02.021","volume":"34","author":"SP Georgiadou","year":"2015","unstructured":"Georgiadou, S. P. et al. Current clinical, laboratory, and treatment outcome characteristics of visceral leishmaniasis: Results from a seven-year retrospective study in Greece. Int. J. Infect. Dis. 34(1), 46\u201350 (2015).","journal-title":"Int. J. Infect. Dis."},{"key":"28139_CR42","doi-asserted-by":"crossref","unstructured":"Ferede, G. et al. Visceral leishmaniasis-malaria coinfection and their associated factors in patients attending Metema Hospital, Northwest Ethiopia. Malar. Res. Treat. 2017 (2017).","DOI":"10.1155\/2017\/6816913"},{"issue":"1","key":"28139_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-3865-y","volume":"19","author":"Y Aschale","year":"2019","unstructured":"Aschale, Y. et al. Malaria-visceral leishmaniasis co-infection and associated factors among migrant laborers in West Armachiho district, North West Ethiopia. BMC Infect. Dis. 19(1), 1\u20137 (2019).","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"28139_CR44","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/j.1365-3156.2010.02550.x","volume":"15","author":"Z Hurissa","year":"2010","unstructured":"Hurissa, Z. et al. Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Trop. Med. Int. Health. 15(7), 848\u2013855 (2010).","journal-title":"Trop. Med. Int. Health."},{"issue":"5","key":"28139_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.11648\/j.ijhpebs.20170305.11","volume":"3","author":"T Eyasu","year":"2017","unstructured":"Eyasu, T., Kinfe, F., Terefe, B. & Enawgaw, B. Haematological abnormalities in visceral leishmaniasis patients attending Gondar University Hospital; retrospective study. Int. J. HIV\/AIDS Prev. Educ. Behav. Sci. 3(5), 48 (2017).","journal-title":"Int. J. HIV\/AIDS Prev. Educ. Behav. Sci."},{"issue":"3","key":"28139_CR46","first-page":"31","volume":"2","author":"AE-S El-Safi","year":"2016","unstructured":"El-Safi, A.E.-S., Adm, A.-S.K. & Hamza, K. M. Hematological profile of patients with visceral leishmaniasis at Al-Gaderf State. Sudan. Clin. Med. 2(3), 31\u201339 (2016).","journal-title":"Sudan. Clin. Med."},{"issue":"3","key":"28139_CR47","doi-asserted-by":"publisher","first-page":"e0150406","DOI":"10.1371\/journal.pone.0150406","volume":"11","author":"B Sarkari","year":"2016","unstructured":"Sarkari, B., Naraki, T., Ghatee, M. A., AbdolahiKhabisi, S. & Davami, M. H. Visceral leishmaniasis in Southwestern Iran: A retrospective clinico-hematological analysis of 380 consecutive hospitalized cases (1999\u20132014). PLoS ONE 11(3), e0150406 (2016).","journal-title":"PLoS ONE"},{"issue":"1","key":"28139_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-021-06691-7","volume":"21","author":"E Shiferaw","year":"2021","unstructured":"Shiferaw, E. et al. Hematological profiles of visceral leishmaniasis patients before and after treatment of anti-leishmanial drugs at University of Gondar Hospital; Leishmania Research and Treatment Center Northwest, Ethiopia. BMC Infect. Dis. 21(1), 1\u20137 (2021).","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"28139_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12878-018-0123-2","volume":"18","author":"T Mulaw","year":"2018","unstructured":"Mulaw, T., Tariku, A., Tsegaye, A. T. & Abebe, Z. Effect of iron-folic acid supplementation on change of hemoglobin among visceral Leishmaniasis patients in northwest Ethiopia: A retrospective follow up study. BMC Hematol. 18(1), 1\u20137 (2018).","journal-title":"BMC Hematol."},{"issue":"5","key":"28139_CR50","first-page":"EC39","volume":"10","author":"SS Chufal","year":"2016","unstructured":"Chufal, S. S. et al. Role of haematological changes in predicting occurrence of leishmaniasis-a study in kumaon region of Uttarakhand. J. Clin. Diagn. Res. 10(5), EC39 (2016).","journal-title":"J. Clin. Diagn. Res."},{"issue":"3","key":"28139_CR51","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12288-010-0027-1","volume":"26","author":"N Varma","year":"2010","unstructured":"Varma, N. & Naseem, S. Hematologic changes in visceral leishmaniasis\/kala azar. Indian J. Hematol. Blood Transfus. 26(3), 78\u201382 (2010).","journal-title":"Indian J. Hematol. Blood Transfus."},{"issue":"6","key":"28139_CR52","doi-asserted-by":"publisher","first-page":"36","DOI":"10.22192\/ijcrms.2017.03.06.005","volume":"3","author":"N Neki","year":"2017","unstructured":"Neki, N. & Singh, J. Hematological changes in visceral leishmaniasis. Int. J. Curr. Res. Med. Sci. 3(6), 36\u201340 (2017).","journal-title":"Int. J. Curr. Res. Med. Sci."},{"issue":"2","key":"28139_CR53","first-page":"143","volume":"44","author":"S Chakrabarti","year":"2013","unstructured":"Chakrabarti, S., Sarkar, S., Goswami, B. K., Sarkar, N. & Das, S. Clinico-hematological profile of visceral leishmaniasis among immunocompetent patients. Southeast Asian J. Trop. Med. Public Health 44(2), 143 (2013).","journal-title":"Southeast Asian J. Trop. Med. Public Health"},{"issue":"1","key":"28139_CR54","first-page":"1","volume":"9","author":"AT Naeem","year":"2014","unstructured":"Naeem, A. T. et al. Clinical features and laboratory findings of visceral leishmaniasis in children referred to Children Medical Center Hospital, Tehran, Iran during 2004\u20132011. Iran. J. Parasitol. 9(1), 1 (2014).","journal-title":"Iran. J. Parasitol."},{"issue":"8","key":"28139_CR55","first-page":"1","volume":"2","author":"B Preeti","year":"2013","unstructured":"Preeti, B., Shriram, G. & Puneet, K. Haematological parameters in visceral leishmaniasis. Int. J. Pharm. Sci. Invent. 2(8), 1\u20138 (2013).","journal-title":"Int. J. Pharm. Sci. Invent."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28139-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28139-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T10:59:02Z","timestamp":1728730742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-023-28139-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,17]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["28139"],"URL":"https:\/\/doi.org\/10.1038\/s41598-023-28139-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,17]]},"assertion":[{"value":"2 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"931"}}